These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 14983937)

  • 1. ATM protein overexpression in prostate tumors: possible role in telomere maintenance.
    Angèle S; Falconer A; Foster CS; Taniere P; Eeles RA; Hall J
    Am J Clin Pathol; 2004 Feb; 121(2):231-6. PubMed ID: 14983937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrence.
    Seligson DB; Hongo F; Huerta-Yepez S; Mizutani Y; Miki T; Yu H; Horvath S; Chia D; Goodglick L; Bonavida B
    Clin Cancer Res; 2007 Oct; 13(20):6056-63. PubMed ID: 17947468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion.
    Bethel CR; Faith D; Li X; Guan B; Hicks JL; Lan F; Jenkins RB; Bieberich CJ; De Marzo AM
    Cancer Res; 2006 Nov; 66(22):10683-90. PubMed ID: 17108105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telomere shortening is an early somatic DNA alteration in human prostate tumorigenesis.
    Meeker AK; Hicks JL; Platz EA; March GE; Bennett CJ; Delannoy MJ; De Marzo AM
    Cancer Res; 2002 Nov; 62(22):6405-9. PubMed ID: 12438224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of QM protein expression correlates with tumor grade in prostatic adenocarcinoma.
    Altinok G; Powell IJ; Che M; Hormont K; Sarkar FH; Sakr WA; Grignon D; Liao DJ
    Prostate Cancer Prostatic Dis; 2006; 9(1):77-82. PubMed ID: 16331298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer.
    Ryan CJ; Haqq CM; Simko J; Nonaka DF; Chan JM; Weinberg V; Small EJ; Goldfine ID
    Urol Oncol; 2007; 25(2):134-40. PubMed ID: 17349528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGA2 expression in a canine model of prostate cancer.
    Winkler S; Murua Escobar H; Meyer B; Simon D; Eberle N; Baumgartner W; Loeschke S; Nolte I; Bullerdiek J
    Cancer Genet Cytogenet; 2007 Sep; 177(2):98-102. PubMed ID: 17854662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate stem cell antigen mRNA expression in preoperatively negative biopsy specimens predicts subsequent cancer after transurethral resection of the prostate for benign prostatic hyperplasia.
    Zhao Z; Liu J; Li S; Shen W
    Prostate; 2009 Sep; 69(12):1292-302. PubMed ID: 19462463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of Fas and FLIP in prostate cancers.
    Kim SY; Song SY; Kim MS; Lee JY; Lee HM; Choi HY; Yoo NJ; Lee SH
    APMIS; 2009 Jan; 117(1):28-33. PubMed ID: 19161534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate.
    Arora R; Koch MO; Eble JN; Ulbright TM; Li L; Cheng L
    Cancer; 2004 Jun; 100(11):2362-6. PubMed ID: 15160339
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgen-independent cancer.
    Montironi R; Mazzucchelli R; Barbisan F; Stramazzotti D; Santinelli A; Scarpelli M; Lòpez Beltran A
    Hum Pathol; 2006 Sep; 37(9):1137-44. PubMed ID: 16938518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence of multifocality of telomere erosion in high-grade prostatic intraepithelial neoplasia (HPIN) and concurrent carcinoma.
    Vukovic B; Park PC; Al-Maghrabi J; Beheshti B; Sweet J; Evans A; Trachtenberg J; Squire J
    Oncogene; 2003 Apr; 22(13):1978-87. PubMed ID: 12673203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
    Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
    Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of erythropoietin receptor in human prostate carcinoma and high-grade prostatic intraepithelial neoplasia.
    Zhou T; Xu C; He M; Sun Y
    Prostate Cancer Prostatic Dis; 2008; 11(2):143-7. PubMed ID: 17637760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical analysis of NF-kappaB signaling proteins IKKepsilon, p50/p105, p52/p100 and RelA in prostate cancers.
    Seo SI; Song SY; Kang MR; Kim MS; Oh JE; Kim YR; Lee JY; Yoo NJ; Lee SH
    APMIS; 2009 Aug; 117(8):623-8. PubMed ID: 19664134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate-specific antigen mRNA and protein levels in laser microdissected cells of human prostate measured by real-time reverse transcriptase-quantitative polymerase chain reaction and immuno-quantitative polymerase chain reaction.
    Pinzani P; Lind K; Malentacchi F; Nesi G; Salvianti F; Villari D; Kubista M; Pazzagli M; Orlando C
    Hum Pathol; 2008 Oct; 39(10):1474-82. PubMed ID: 18619642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlations of telomere length, telomerase activity, and telomeric-repeat binding factor 1 expression in colorectal carcinoma.
    Garcia-Aranda C; de Juan C; Diaz-Lopez A; Sanchez-Pernaute A; Torres AJ; Diaz-Rubio E; Balibrea JL; Benito M; Iniesta P
    Cancer; 2006 Feb; 106(3):541-51. PubMed ID: 16388518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of human leukocyte antigen-G (HLA-G) messenger RNAs and proteins in normal human prostate and prostatic adenocarcinoma.
    Langat DK; Sue Platt J; Tawfik O; Fazleabas AT; Hunt JS
    J Reprod Immunol; 2006 Aug; 71(1):75-86. PubMed ID: 16616377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.
    Rehman I; Azzouzi AR; Cross SS; Deloulme JC; Catto JW; Wylde N; Larre S; Champigneuille J; Hamdy FC
    Hum Pathol; 2004 Nov; 35(11):1385-91. PubMed ID: 15668896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomere-mediated genomic instability and the clinico-pathological parameters in breast cancer.
    Poonepalli A; Banerjee B; Ramnarayanan K; Palanisamy N; Putti TC; Hande MP
    Genes Chromosomes Cancer; 2008 Dec; 47(12):1098-109. PubMed ID: 18720522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.